| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/14/2002 | EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229934A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 08/14/2002 | EP1229923A1 Inhibition of pathogens by bacillus coagulans strains |
| 08/14/2002 | EP1229897A2 Personal care articles comprising cationic polymer coacervate compositions |
| 08/14/2002 | EP1229894A1 Cosmetic compositions containing chick pea extract and retinoids |
| 08/14/2002 | EP1063981B1 Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage |
| 08/14/2002 | EP0892642B1 Use in a composition of an extract of at least one labiate of the genus rosmarinarus, cultured in vitro |
| 08/14/2002 | EP0855903B1 Cosmetic composition for the treatment of keratinous materials comprising at least a grafted silicone polymer and at least an aqueous dispersion of insoluble particles of non ionic or cationic polymer |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | DE10105038A1 Tripeptide und Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364082A Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having same effective composition |
| 08/14/2002 | CN1364073A Skin care composition for mediating cell to cell communication |
| 08/14/2002 | CN1364056A Pyrithione biocides enhanced by silver, copper, or zinc ions |
| 08/14/2002 | CN1363393A Process for preparing health-care compound sheep placenta extract food series |
| 08/14/2002 | CN1363389A Chinese medicine in form of instant particles for treating dermatopathy |
| 08/14/2002 | CN1363379A Mongolian-medicinal liniment for disinfecting skin |
| 08/14/2002 | CN1363378A Medicine prepared from sun euphorbia herb for treating flat wart |
| 08/14/2002 | CN1363376A Medicine for treating dermatopathy |
| 08/14/2002 | CN1363368A Ointment 'Yiyoujing' |
| 08/14/2002 | CN1363365A Extraction of herbs by heating alcohol |
| 08/14/2002 | CN1363361A Fast-acting Shengji San |
| 08/14/2002 | CN1363358A Chinese-medicinal ointment for treating burn and scald and its preparing process |
| 08/14/2002 | CN1363356A Multifunctional plaster |
| 08/14/2002 | CN1363350A Chinese medicine for treating psoriasis |
| 08/14/2002 | CN1363319A Medicine and method for treating psoriasis |
| 08/14/2002 | CN1363278A Itch-tinea mixture |
| 08/14/2002 | CN1363276A Exterior-applied medicine 'Shufushan' for treating dermatopathy |
| 08/14/2002 | CN1363269A Spot-removing antiwrinkle cream |
| 08/14/2002 | CN1089001C Itching-stopping chili liquid and its preparation |
| 08/14/2002 | CN1088996C Compounded Chinese medical cream for curing scars |
| 08/14/2002 | CN1088994C Medicinal composition for treating foot ringworm |
| 08/14/2002 | CN1088990C Chrysanthemum medicinal bath lotion and preparation method thereof |
| 08/13/2002 | US6433202 Antiinflammatory agents |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6433096 Sterilized cyanoacrylate solutions containing thickeners |
| 08/13/2002 | US6433021 Antiinflammatory agents; mast cell stabilizers |
| 08/13/2002 | US6433006 Method of treatment of seborrheic dermatitis |
| 08/13/2002 | US6433001 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 08/13/2002 | US6432996 Pharmaceutical composition |
| 08/13/2002 | US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents |
| 08/13/2002 | US6432978 4-hydroxy-1-methyl-1,2-dihydroquinolin-2-one derivatives; cardiovascular, atopic, and rheumatic disorders; antiallergens, antiinflammatory agents, antiasthmatics, and hypotensive agents |
| 08/13/2002 | US6432962 Antiinflammatory agents |
| 08/13/2002 | US6432949 Amide derivatives useful as inhibitors of the production of cytokines |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | US6432940 Uses for androst-5-ene-3β, 17β-diol |
| 08/13/2002 | US6432922 Antitumor agents; angiogenesis inhibitors |
| 08/13/2002 | US6432659 Motor proteins and methods for their use |
| 08/13/2002 | US6432452 Topical administering a 20-acetyl-ingenol-3-angelate obtained from plant extracts having preferential cytolysis for cancer cells; metallothionein gene promotors having chemical and heat resistance |
| 08/13/2002 | US6432432 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles |
| 08/13/2002 | US6432431 Steroid-containing cataplasms and process for producing the same |
| 08/13/2002 | US6432397 Upon hydrolysis, releases conjugates of nonpeptidic polymers and biologically active molecules with an amino group; peg and protein conjugates released in vivo; peg has at least one hydrolytically unstable linkage in its backbone, such as ester |
| 08/12/2002 | CA2370236A1 Method for inhibiting retinoid skin damage |
| 08/12/2002 | CA2369967A1 Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| 08/08/2002 | WO2002061110A2 Nucleic acid derivatives |
| 08/08/2002 | WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | WO2002060942A2 Protein modification and maintenance molecules |
| 08/08/2002 | WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060897A2 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060864A1 Process of obtaining compositions of stable lutein and lutein derivatives |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002060501A2 Hydrogel wound dressing,preparation and use thereof |
| 08/08/2002 | WO2002060492A1 Methods of inhibiting kinases |
| 08/08/2002 | WO2002060489A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/08/2002 | WO2002060483A2 Perylenequinones for use as photosensitizers and sonosensitizers |
| 08/08/2002 | WO2002060482A2 Perylenequinones for use with immunotherapy agents |
| 08/08/2002 | WO2002060480A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | WO2002060464A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use |
| 08/08/2002 | WO2002060458A2 Compositions and method of tissue superoxygenation |
| 08/08/2002 | WO2002060456A1 Treatment of angiogenesis-dependent conditions with dextrin sulphates |
| 08/08/2002 | WO2002060455A1 Methods and compositions utilizing 2'-5' oligoadenylates in the treatment of disorders of cell proliferation |
| 08/08/2002 | WO2002060434A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | WO2002060396A2 Hair follicle neogenesis by injection of follicle progenitor cells |
| 08/08/2002 | WO2002060395A1 Cosmetics |
| 08/08/2002 | WO2002060388A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK) |
| 08/08/2002 | WO2002060382A2 Novel compounds and uses thereof |
| 08/08/2002 | WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | WO2002045699A3 Transdermal therapeutic system comprising the active ingredient oxybutynin |
| 08/08/2002 | WO2002036094A3 Method and dermatological and/or cosmetic composition for inhibiting the adhesion effect of circulating cells |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 08/08/2002 | WO2002019971A9 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 08/08/2002 | WO2002011747A3 Transglutaminase for inhibiting angiogenesis |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002009690A3 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 08/08/2002 | WO2002007729A9 Non-sedating barbiturate compounds as neuroprotective agents |
| 08/08/2002 | WO2002000840A3 Human lyases |
| 08/08/2002 | WO2002000631A3 Benzhydryl derivatives |
| 08/08/2002 | WO2002000142A3 Intervertebral disc |